Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-24-199462
Filing Date
2024-08-13
Accepted
2024-08-13 09:06:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d882336dsc13ga.htm SC 13G/A 47781
  Complete submission text file 0001193125-24-199462.txt   49626
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filed by) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 450 EAST 29TH STREET 15TH FLOOR NEW YORK NY 10016
Business Address 450 EAST 29TH STREET 15TH FLOOR NEW YORK NY 10016 6464902965
MeiraGTx Holdings plc (Subject) CIK: 0001735438 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90529 | Film No.: 241199047
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)